“The risk of developing ALCL is actually much lower than the risk of experiencing a relapse of breast cancer,” says lead author Connor J. Kinslow, MD, a resident in radiation oncology at the Columbia University Vagelos College of Physicians and Surgeons.
“Based on our findings, we do not believe that women should be dissuaded from having implant-based breast reconstruction after mastectomy solely due to the risk of ALCL.”
The new study was designed to provide women with accurate information about risk and is the first to look at rates of ALCL in breast cancer survivors who’ve had breast implants after mastectomy.
Comments are closed.